<DOC>
	<DOC>NCT02729012</DOC>
	<brief_summary>The main objective of RinASol project is to assess in patients with seasonal Allergic Rhinitis the effect of hypertonic saline solution NACL 3%+NAHCO3 vs the effect of standard saline solution on nasal inflammation by means of nasal cytology. The secondary objective is the symptom score assessment by T5SS Questionnaire (Total Symptom Score 5)</brief_summary>
	<brief_title>Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Clinical history of Allergic Rhinitis (for at least 1 year) 6 years old ≤ children age ≤ 14 years old Total Symptom Score 5: &gt;5 in the last 4 days before screening. Exclusion Criteria Signs of acute infections of upper and lower respiratory tract. Metabolic, immunological, systemic diseases Respiratory tract deformity Systemic/Topical therapies with antibiotics or corticosteroids in the previous 30 days. Active smoker.</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Children</keyword>
</DOC>